954 results on '"Lee, Grace M."'
Search Results
52. Understanding pediatric long COVID using a tree-based scan statistic approach: An EHR-based cohort study from the RECOVER Program
53. The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21)
54. Risk of anaphylaxis after vaccination in children and adults
55. Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007–2013
56. Sickle red blood cells directly activate neutrophils.
57. Making Smart Choices: A Serious Game for Sex Education for Young Adolescents
58. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination--PCORnet, United States, January 2021-January 2022
59. The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged [greater than or equal to]18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines--United States, February 2022
60. Pneumonia in the Immunocompromised Host
61. Contributors
62. Can Multisystem Inflammatory Syndrome in Children Be Managed in the Outpatient Setting? An EHR-Based Cohort Study From the RECOVER Program
63. Leveraging serologic testing to identify children at risk for post-acute sequelae of SARS-CoV-2 infection: An EHR-based cohort study from the RECOVER program
64. Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006
65. Pediatric Nirmatrelvir/Ritonavir Prescribing Patterns During the COVID-19 Pandemic
66. A machine learning-based phenotype for long COVID in children: an EHR-based study from the RECOVER program
67. Understanding pediatric long COVID using a tree-based scan statistic approach: An EHR-based cohort study from the RECOVER Program
68. Associations between area-level health-related social factor indices and risk of acute COVID-19: An EHR-based cohort study from the RECOVER program
69. Additional file 1 of Moms in the NICU: developing a pilot to engage and empower women who have delivered a prematurely born infant
70. Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices--United States, December 2021
71. Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged [greater than or equal to] 19 Years: Recommendations of the Advisory Committee on Immunization Practices--United States, 2022
72. Impact of SARS-CoV-2 infection on disease trajectory in youth with T1D: An EHR-based cohort study from the RECOVER program
73. Changes in Treatment and Severity of Multisystem Inflammatory Syndrome in Children: An EHR-based cohort study from the RECOVER program
74. Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents
75. Clinical Subphenotypes of Multisystem Inflammatory Syndrome in Children: An EHR-based cohort study from the RECOVER program
76. The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety
77. Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events
78. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years--United States, November 2021
79. Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged [greater than or equal to] 16 Years: Recommendations of the Advisory Committee on Immunization Practices--United States, September 2021
80. Central Line–Associated Bloodstream Infections in Neonates with Gastrointestinal Conditions: Developing a Candidate Definition for Mucosal Barrier Injury Bloodstream Infections
81. Impact of Medicare’s Payment Policy on Mediastinitis Following Coronary Artery Bypass Graft Surgery in US Hospitals
82. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices--United States, July 2021
83. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices--United States, June 2021
84. Multisystem Inflammatory Syndrome in Children Managed in the Outpatient Setting: An EHR-based cohort study from the RECOVER program
85. Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022
86. Neutrophil functional heterogeneity is a fixed phenotype and is associated with distinct gene expression profiles
87. Healthcare utilization following SARS-CoV-2 infection in children and adolescents with chronic conditions: An EHR-based Cohort Study from the RECOVER Program
88. Pediatric surgical site infections in 287 hospitals in the United States, 2015–2018
89. Leveraging serology testing to identify children at risk for post-acute sequelae of SARS-CoV-2 infection: An EHR-based cohort study from the RECOVER program
90. High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass
91. Factors Associated With Pediatric Ventilator-Associated Conditions in Six U.S. Hospitals: A Nested Case-Control Study*
92. Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy
93. A Pediatric Approach to Ventilator-Associated Events Surveillance
94. iTTP loses TPE
95. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years--United States, May 2021
96. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients--United States, April 2021
97. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine--United States, February 2021
98. Recommended Adult Immunization Schedule, United States, 2023.
99. Use of recombinant zoster vaccine in immunocompromised adults aged ≥19 years: Recommendations of the Advisory Committee on Immunization Practices—United States, 2022
100. Clinical features and burden of post-acute sequelae of SARS-CoV-2 infection in children and adolescents: an exploratory EHR-based cohort study from the RECOVER program
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.